Natco Pharma Ltd. Earnings/Conference Calls

Natco Pharma Ltd has submitted to BSE a copy of Presentation made to analysts /Investors for the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2016.

pdf

Natco Pharma Ltd.

03 Jun 2016

840.80

-0.59%

Investor Presentation

Presentation made to analysts / Investors

BSE India

Natco Pharma Ltd has submitted to BSE a copy of the presentation made to analysts /Investors on Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2016.

pdf

Natco Pharma Ltd.

26 Feb 2016

840.80

-0.59%

Investor Presentation

Presentation made to analysts / Investors

BSE India

Natco Pharma Ltd has submitted to BSE a copy of Presentation made to analysts /Investors on un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2015.

pdf

Is Natco Pharma Ltd. worth buying?

577 Votes:

Buy 83.02%

Sell 7.28%

Hold 9.71%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf

44.13% Fall from 52W High

Natco Pharma Ltd. Earnings/Conference Calls

Natco Pharma Ltd. earnings concalls and investor presentations